NCT05696054 (SBP) is a clinical trial in Spontaneous Bacterial Peritonitis, sponsored by Sohag University.

Who is sponsoring NCT05696054?

NCT05696054 is sponsored by Sohag University.

What condition does NCT05696054 study?

NCT05696054 studies Spontaneous Bacterial Peritonitis.

Is NCT05696054 still recruiting?

NCT05696054 is currently status unknown. Last updated 25 January 2023.

Last reviewed 2023-01-25 · How we verify

NCT05696054: SBP

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Laboratory Diagnosis of Spontaneous Bacterial Peritonitis

Status unknown Last updated 25 January 2023

What this trial tests

trial in Spontaneous Bacterial Peritonitis in 80 participants. Status unknown.

Timeline

15 February 2023

Primary endpoint
15 July 2023

15 September 2023

Quick facts

Lead sponsor	Sohag University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	80
Start date	15 February 2023
Primary completion	15 July 2023
Estimated completion	15 September 2023

Conditions studied

Spontaneous Bacterial Peritonitis — all drugs for Spontaneous Bacterial Peritonitis →

Sponsor

Sohag University

Who can join

18 and older, any sex, with Spontaneous Bacterial Peritonitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims at evaluating the diagnostic accuracy of serum procalcitonin, PEC index, modified Wehmeyer, and Mansoura scoring systems for SBP in cirrhotic patients with ascites

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Spontaneous Bacterial Peritonitis

Currently open trials in the same condition.

NCT06026267 — Efficacy of Conventional Dose Protocol vs Low Dose Protocol Albumin Use in Patients With Cirrhosis and High Risk Spontan · NA · recruiting
NCT04168099 — Oral Gemifloxacin Versus Intravenous Cefotaxime in Treatment of Spontaneous Bacterial Peritonitis · Phase 3 · recruiting
NCT04161768 — Norfloxacin With Itopride Versus Norfloxacin in Secondary Prophylaxis of Spontaneous Bacterial Peritonitis · Phase 3 · recruiting

Other Sohag University trials

Trials by the same sponsor.

NCT07119905 — Association Between Matrix Metalloproteinase-9 Gene Polymorphism and Susceptibility to Primary Open Angle Glaucoma Patie · not yet recruiting
NCT07512219 — Comparison Between Greater Occipital Nerve Block and Pulsed Radiofrequency in the Management of Chronic Migraine · NA · not yet recruiting
NCT07519694 — Comparative Study Between Different Additives to Lidocaine 2٪ for Peribulbar Block in Vitreoretinal Surgery · NA · not yet recruiting
NCT07515365 — Colitis Patterns in Patients With Lower GI Symptoms · not yet recruiting
NCT07523386 — Compartive Study Between Cannulated Screw and Kws in Fixation of Distal Radius · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05696054 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sohag University
Last refreshed: 25 January 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05696054.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing